RxDoctor Payments Data

Nicole Isaac, APRN

Family · Pikeville, KYNPI 1215358411

Payments from drug & device makers

$2,883in general payments, 2019–2025

Across 187 payments — averaging $15.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$812
  • Amgen$497
  • Bayer$232
  • Daiichi Sankyo Inc.$188
  • Phathom Pharmaceuticals, Inc.$169
  • Biohaven Pharmaceuticals, Inc.$151
  • plus $834 from 16 others

What the payments were for

  • Food & beverage$2,883100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,883 in reported general payments places this provider in the 85th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$11,450
Medicare patients
91
Services billed
511

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide31$27,919
TrulicityDulaglutide28$24,870
Repatha SureclickEvolocumab18$20,184
FarxigaDapagliflozin Propanediol11$17,231
LinzessLinaclotide15$17,170
MounjaroTirzepatide13$13,302
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$10,745
MovantikNaloxegol Oxalate15$6,269
Lantus SolostarInsulin Glargine,hum.Rec.Anlog18$2,186
Novolog FlexpenInsulin Aspart12$1,870
Buspirone Hcl89$1,229
Colestipol Hcl13$1,188
Albuterol Sulfate HfaAlbuterol Sulfate27$1,165
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen85$986
Pantoprazole Sodium114$983

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$130$38,17241 claims
AstraZenecaFarxiga, Breztri Aerosphere$75$27,97623 claims
AbbVieLinzess$812$17,17015 claims
Redhill Biopharma Inc.Movantik$78$6,26915 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,374 family providers in Kentucky.

Other family in Pikeville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →